首页 > 文献资料
-
以国际合作项目的理念和方法开展优质服务
太仓市位于江苏省东南边缘长江口南岸,西离苏州57公里,东南距上海53公里,总面积815平方公里,陆地面积648平方公里,总人口45万,下辖12个镇;是中国国际合作计划生育结合项目第一周期试点区.1984~1986年在原7个镇12万人口范围内进行试点,自87年起向全市推广.进入九十年代,在总结国际合作结合项目成功经验的基础上,结合当地实际,又借鉴了日本预防保健的经验,于1994年建立太仓市家庭保健服务中心;1995年6月以来逐步在全市12个镇建立了家庭保健服务所,突出以改善和提高妇女、儿童、老年健康为重点的生殖保健优质服务工作.
-
艾滋病预防与计划生育服务结合国际合作项目取得进展
为更好促进艾滋病预防与计划生育服务结合,2003年开始,在中国/联合国人口基金生殖健康/计划生育项目框架下,确定江苏盐都、河南扶沟、广东惠州惠城、广西柳江、四川安县、云南沾益、甘肃敦煌、新疆喀什为项目试点地区,开展了相应的项目活动.
-
日本家族计划国际协力财团(JOICFP)与结合项目
日本家族计划国际协力财团(Japanese Organization for International Cooperation in Family Planning,JOICFP)成立于1968年,是日本人口与生殖健康领域重要的非政府组织.多年来,JOICFP致力于全球特别是发展中国家人口与计划生育事业的发展,通过结合(IP)项目,将日本战后保健卫生方面的经验介绍到其他国家.通过多种渠道在国内外宣传募集资金,在人力资源培训、推广日本先进的妇幼保健、预防医学经验方面取得了巨大成就并获得国际上广泛认可.2001年JOICFP获得联合国人口奖团体奖.
-
关于组织天然药物、保健食品国际市场营销和经营管理培训团访问日本、韩国的通知
-
The outcome of hepatocellular carcinoma (HCC) patients significantly differs between western and eastern population centers. Our group previously developed and validated the Chinese University Prognostic Index (CUPI) for the prognostication of HCC among the Asian HCC patient population. In the current study, we aimed to validate the CUPI using an international cohort of patients with HCC and to compare the CUPI to two widely used staging systems, the Barcelona Clinic Liver Cancer (BCLC) classification and the Cancer of the Liver Italian Program (CLIP). To accomplish this goal, two cohorts of patients were enrolled in the United Kingdom (UK;n = 567; 2006-2011) and Hong Kong (HK;n = 517; 2007-2012). The baseline clinical data were recorded. The performances of the CUPI, BCLC, and CLIP were compared in terms of a concordance index (C-index) and were evaluated in subgroups of patients according to treatment intent. The results revealed that the median folow-up durations of the UK and HK cohorts were 27.9 and 29.8 months, respectively. The median overal survival of the UK and HK cohorts were 22.9 and 8.6 months, respectively. The CUPI stratified the patients in both cohorts into three risk subgroups corresponding to distinct outcomes. The median overal survival of the CUPI low-, intermediate-, and high-risk subgroups were 3.15, 1.24, and 0.29 years, respectively, in the UK cohort and were 2.07, 0.32, and 0.10 years, respectively, in the HK cohort. For the patients who underwent curative treatment, the prognostic performance did not differ between the three staging systems, and all were suboptimal. For those who underwent paliative treatment, the CUPI displayed the highest C-index, indicating that this staging system was the most informative for both cohorts. In conclusion, the CUPI is applicable to both western and eastern HCC patient populations. The performances of the three staging systems differed according to treatment intent, and the CUPI was demonstrated to be optimal for those undergoing paliative treatment. A more precise staging system for early-stage disease patients is required.